EquityZen Growth Technology Fund LLC - Series 1792
Raised
$2M
Investors
68
Min Invest
$10,004
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1792 is a Delaware pooled investment fund that raised $1.9M from 68 investors with a $10K minimum investment under Rule 506(b) and Section 3(c)(1) exemptions. Filed September 14, 2023 by EquityZen Advisors LLC and Philip Haslett, this entity is part of the EquityZen platform, which operates over 150 related EDGAR entities focused on private equity investments.
This filing follows a typical venture capital fund structure using the 506(b) private placement exemption combined with the 3(c)(1) Investment Company Act exemption for funds with fewer than 100 beneficial owners. The $10K minimum investment represents a lower-than-typical threshold for private equity, consistent with EquityZen's platform model of democratizing access to private company shares through SPV-style vehicles.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
Philip Haslett
Executive Officer, Director · New York, NY
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. AltStreet analysis (summaries, flags, category context) is generated by Claude from this primary source data and reviewed for accuracy. Platform-provided information (if present) is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. EDGAR data is verified read-only — platforms may request factual corrections for demonstrable inaccuracies by contacting research@altstreet.investments. This page does not constitute investment advice.
